Related Experiment Video
Updated: Apr 19, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
5.4K
Management of strabismus in thyroid eye disease
1The Bristol Eye Hospital, Bristol, UK.
Eye (London, England)
|December 20, 2014
Summary
Thyroid eye disease management involves controlling inflammation with medications and radiation, followed by strabismus surgery. Surgery aims to improve eye movement and single vision, but realistic expectations are crucial.
Area of Science:
- Ophthalmology
- Endocrinology
- Autoimmune Diseases
Background:
- Thyroid eye disease (TED) is an autoimmune condition with inflammatory and fibrotic phases.
- It can cause restricted eye movements and double vision (diplopia).
- Current treatments include steroids, radiotherapy, and immunosuppression to manage inflammation.
Purpose of the Study:
- To outline the management of thyroid eye disease.
- To detail the role and timing of strabismus surgery in TED patients.
- To discuss surgical techniques and patient expectations.
Main Methods:
- Review of medical and surgical management strategies for TED.
- Focus on the timing of strabismus surgery post-inflammation and decompression.
- Description of surgical techniques, including adjustable sutures for muscle recession.
Main Results:
- Medical treatments can control the active inflammatory phase of TED.
- Strabismus surgery is effective after inflammation subsides and decompression is complete.
- Adjustable sutures maximize binocular single vision, though debated for the inferior rectus.
Conclusions:
- Effective management of thyroid eye disease requires a phased approach.
- Strabismus surgery, when timed appropriately, can restore binocular single vision.
- Patient education regarding realistic outcomes, including potential worsening of lid retraction, is essential.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Accessory Structures of the Eye
4.8K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
4.8K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Graves' Disease I: Introduction
6
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
6
Graves Disease II: Pathophysiology
7
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
7

